Scott Macdonald1, Cheryl J Cherpitel2, Tim Stockwell3, Gina Martin4, Sonya Ishiguro4, Kate Vallance4, Jeff Brubacher5. 1. Centre for Addictions Research of BC: PO Box 1400 STNCSC Victoria BC V8W 2Y2 Canada, Professor, School of Health Information Science, University of Victoria, BC. 2. Alcohol Research Group, Emeryville, CA: 6475 Christie Avenue, Suite 400 Emeryville, CA 94608-1010, Centre for Addictions Research of BC: PO Box 1400 STNCSC Victoria BC V8W 2Y2 Canada. 3. Centre for Addictions Research of BC: PO Box 1400 STNCSC Victoria BC V8W 2Y2 Canada and Department of Psychology, University of Victoria, BC. 4. Centre for Addictions Research of BC, University of Victoria, BC: PO Box 1400 STNCSC Victoria BC V8W 2Y2 Canada. 5. Department of Emergency Medicine, University of British Columbia: JPPN, Vancouver General Hospital, Room 3303 910 West 10th Ave, Vancouver, V5Z1M9, BC Canada.
Abstract
The purpose of this study was to assess the concordance of self-reports of cannabis, cocaine and amphetamines, and the utility of these, with a saliva point of collection drug test, the DrugWipe 5+, in an emergency department (ED) setting. METHODS: A random sample of people admitted to either of two emergency departments at hospitals in British Columbia, Canada were asked to participate in an interview on their substance use and provide a saliva test for detection of drugs. ANALYSES: Concordance of self-reports and drug tests were calculated. Prior DrugWipe 5+ sensitivity and specificity estimates were compared against a gold standard of mass spectrometry and chromatography (MS/GC). This was used as a basis to assess the truthfulness of self-reports for each drug. RESULTS: Of the 1584 patients approached 1190 agreed to participate, a response rate of 75.1%. For cannabis, among those who acknowledged use only 21.1% had a positive test and 2.1% of those who reported no use had a positive test. For cocaine and amphetamines respectively, 50.0% and 57.1% tested positive among those reporting use, while 2.1% and 1.3%, respectively reported no use and tested positive. Self-reports of cannabis and amphetamines use appear more truthful than self-reports of cocaine use.
The purpose of this study was to assess the concordance of self-reports of cannabis, cocaine and amphetamines, and the utility of these, with a saliva point of collection drug test, the DrugWipe 5+, in an emergency department (ED) setting. METHODS: A random sample of people admitted to either of two emergency departments at hospitals in British Columbia, Canada were asked to participate in an interview on their substance use and provide a saliva test for detection of drugs. ANALYSES: Concordance of self-reports and drug tests were calculated. Prior DrugWipe 5+ sensitivity and specificity estimates were compared against a gold standard of mass spectrometry and chromatography (MS/GC). This was used as a basis to assess the truthfulness of self-reports for each drug. RESULTS: Of the 1584 patients approached 1190 agreed to participate, a response rate of 75.1%. For cannabis, among those who acknowledged use only 21.1% had a positive test and 2.1% of those who reported no use had a positive test. For cocaine and amphetamines respectively, 50.0% and 57.1% tested positive among those reporting use, while 2.1% and 1.3%, respectively reported no use and tested positive. Self-reports of cannabis and amphetamines use appear more truthful than self-reports of cocaine use.
Entities:
Keywords:
Saliva testing; illicit drug use; self-reports
Authors: Tom Blencowe; Anna Pehrsson; Pirjo Lillsunde; Kari Vimpari; Sjoerd Houwing; Beitske Smink; René Mathijssen; Trudy Van der Linden; Sara-Ann Legrand; Kristof Pil; Alain Verstraete Journal: Forensic Sci Int Date: 2010-12-22 Impact factor: 2.395
Authors: Anna Pehrsson; Tom Blencowe; Kari Vimpari; Antti Impinen; Teemu Gunnar; Pirjo Lillsunde Journal: Int J Legal Med Date: 2010-07-23 Impact factor: 2.686
Authors: Franjo Grotenhermen; Gero Leson; Günter Berghaus; Olaf H Drummer; Hans-Peter Krüger; Marie Longo; Herbert Moskowitz; Bud Perrine; Johannes G Ramaekers; Alison Smiley; Rob Tunbridge Journal: Addiction Date: 2007-10-04 Impact factor: 6.526
Authors: Johanna Gripenberg-Abdon; Tobias H Elgán; Eva Wallin; Marjan Shaafati; Olof Beck; Sven Andréasson Journal: Subst Abuse Treat Prev Policy Date: 2012-02-09
Authors: Erin E Bonar; Maureen A Walton; Kristen L Barry; Amy S B Bohnert; Stephen T Chermack; Rebecca M Cunningham; Lynn S Massey; Rosalinda V Ignacio; Frederic C Blow Journal: Drug Alcohol Depend Date: 2017-12-11 Impact factor: 4.492
Authors: Natalie S Levy; Joseph J Palamar; Stephen J Mooney; Charles M Cleland; Katherine M Keyes Journal: Ann Epidemiol Date: 2022-01-03 Impact factor: 6.996